John Northcott Nektar Therapeutics (NKTR) insider trading activity

John Northcott is SVP & Chief Commercial Officer of NEKTAR THERAPEUTICS. Currently has a direct ownership of 223,210 shares of NKTR, which is worth approximately $207,585. The most recent transaction as insider was on May 16, 2022, when has been sold 4,592 shares (Common Stock) at a price of $3.95 per share, resulting in proceeds of $18,138. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 223K

0% 3M change

0% 12M change

Total Value Held $207,585

JOHN NORTHCOTT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2022	SELL Open market or private sale	$18,138 $3.95 p/Share	4,592 Reduced 2.02%	223,210 Common Stock
Feb 16 2022	SELL Open market or private sale	$53,129 $10.95 p/Share	4,852 Reduced 2.09%	227,802 Common Stock
Dec 16 2021	BUY Grant, award, or other acquisition	-	37,800 Added 13.98%	232,654 Common Stock
Nov 16 2021	SELL Open market or private sale	$79,763 $13.16 p/Share	6,061 Reduced 3.02%	194,854 Common Stock
Aug 16 2021	SELL Open market or private sale	$85,635 $13.83 p/Share	6,192 Reduced 2.99%	200,915 Common Stock
May 17 2021	SELL Open market or private sale	$111,355 $18.3 p/Share	6,085 Reduced 2.85%	207,107 Common Stock
Feb 16 2021	SELL Open market or private sale	$343,558 $22.37 p/Share	15,358 Reduced 6.72%	213,192 Common Stock
Dec 18 2020	BUY Grant, award, or other acquisition	-	28,550 Added 11.1%	228,550 Common Stock

John Northcott

SVP & Chief Commercial Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NKTR shares.

Notify only if

Value

Insider Trading

Get notified when an Nektar Therapeutics insider buys or sells NKTR shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEKTAR THERAPEUTICS

Track Activities on NKTR

Account